Recent Quarter Total Invested
$781.15 M
Recent Quarter Institutional Ownership Percentage
86.6%
Total Invested of Last Quarter
$840.66 M
Ownership Percentage of Last Quarter
77.35%
Centessa Pharmaceuticals plc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| MEDICXI VENTURES MANAGEMENT (JERSEY) LTD | 07/16/2024 | 19.96 M | $180.27 M | 0.00% | 19.99% |
| GENERAL ATLANTIC, L.P. | 08/14/2024 | 9.68 M | $87.43 M | 0.00% | 9.69% |
| ECOR1 CAPITAL, LLC | 08/14/2024 | 5.71 M | $51.60 M | 1.70% | 5.72% |
| FIRST LIGHT ASSET MANAGEMENT, LLC | 08/14/2024 | 4.78 M | $43.17 M | 59.24% | 4.79% |
| PERCEPTIVE ADVISORS LLC | 08/16/2024 | 3.93 M | $35.52 M | 27.57% | 3.94% |
| VIDA VENTURES ADVISORS, LLC | 07/10/2024 | 3.93 M | $35.50 M | 0.00% | 3.94% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 08/14/2024 | 3.53 M | $31.88 M | 19.35% | 3.53% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 08/14/2024 | 3.13 M | $28.22 M | 38.89% | 3.13% |
| TCG CROSSOVER MANAGEMENT, LLC | 08/14/2024 | 2.89 M | $26.10 M | 41.65% | 2.89% |
| FMR LLC | 08/13/2024 | 2.79 M | $25.17 M | 0.00% | 2.79% |
| OCTAGON CAPITAL ADVISORS LP | 08/14/2024 | 2.35 M | $21.18 M | 13.83% | 2.35% |
| ARTAL GROUP S.A. | 08/14/2024 | 2.11 M | $19.08 M | 49.56% | 2.11% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 08/15/2024 | 2.09 M | $18.89 M | 89.49% | 2.09% |
| MORGAN STANLEY | 08/14/2024 | 2.05 M | $18.52 M | -4.07% | 2.05% |
| FARALLON CAPITAL MANAGEMENT LLC | 08/14/2024 | 2.00 M | $18.02 M | 438.01% | 2.00% |
| POINT72 ASSET MANAGEMENT, L.P. | 09/16/2024 | 1.76 M | $15.91 M | -21.96% | 1.76% |
| CORMORANT ASSET MANAGEMENT, LP | 08/14/2024 | 1.61 M | $14.55 M | 186.97% | 1.61% |
| 5AM VENTURE MANAGEMENT, LLC | 08/14/2024 | 1.25 M | $11.24 M | 0.00% | 1.25% |
| FRANKLIN RESOURCES INC | 08/14/2024 | 1.16 M | $10.45 M | 0.00% | 1.16% |
| AFFINITY ASSET ADVISORS, LLC | 08/14/2024 | 1.14 M | $10.26 M | 36.74% | 1.14% |
| BALYASNY ASSET MANAGEMENT L.P. | 08/14/2024 | 1.02 M | $9.24 M | 302.10% | 1.02% |
| AMERICAN CENTURY COMPANIES INC | 08/07/2024 | 935,151 | $8.44 M | 1.30% | 0.94% |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 08/14/2024 | 833,993 | $7.53 M | 100.00% | 0.83% |
| TANAGER WEALTH MANAGEMENT LLP | 07/25/2024 | 696,096 | $6.29 M | 0.00% | 0.70% |
| PFM HEALTH SCIENCES, LP | 08/14/2024 | 635,643 | $5.74 M | 102.00% | 0.64% |
| BAKER BROS. ADVISORS LP | 08/14/2024 | 549,212 | $4.96 M | 100.00% | 0.55% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 08/13/2024 | 495,895 | $4.48 M | 2.21% | 0.50% |
| BLACKROCK INC. | 08/13/2024 | 464,622 | $4.20 M | 21.48% | 0.47% |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 08/20/2024 | 450,000 | $4.06 M | 100.00% | 0.45% |
| TD ASSET MANAGEMENT INC | 08/02/2024 | 321,168 | $2.90 M | 40.47% | 0.32% |
| EXOME ASSET MANAGEMENT LLC | 08/14/2024 | 274,900 | $2.48 M | 0.00% | 0.28% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 08/13/2024 | 253,197 | $2.29 M | 22.40% | 0.25% |
| MARSHALL WACE, LLP | 08/14/2024 | 224,948 | $2.03 M | -2.86% | 0.23% |
| RENAISSANCE TECHNOLOGIES LLC | 08/09/2024 | 173,700 | $1.57 M | -20.61% | 0.17% |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 08/14/2024 | 140,894 | $1.27 M | 30.40% | 0.14% |
| WOODLINE PARTNERS LP | 08/14/2024 | 123,461 | $1.11 M | 100.00% | 0.12% |
| DAFNA CAPITAL MANAGEMENT LLC | 08/14/2024 | 122,882 | $1.11 M | 100.00% | 0.12% |
| MONASHEE INVESTMENT MANAGEMENT LLC | 08/12/2024 | 103,191 | $931,815 | 100.00% | 0.10% |
| HIGHMARK WEALTH MANAGEMENT LLC | 07/29/2024 | 93,000 | $839,790 | 100.00% | 0.09% |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 08/13/2024 | 87,210 | $788,000 | -77.01% | 0.09% |
| BANK OF AMERICA CORP /DE/ | 08/14/2024 | 73,277 | $661,692 | -4.82% | 0.07% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 08/14/2024 | 68,900 | $622,167 | -0.30% | 0.07% |
| GSA CAPITAL PARTNERS LLP | 08/15/2024 | 56,383 | $509,000 | 314.98% | 0.06% |
| TWO SIGMA INVESTMENTS, LP | 08/14/2024 | 51,800 | $467,754 | -34.25% | 0.05% |
| MILLENNIUM MANAGEMENT LLC | 08/14/2024 | 49,485 | $446,850 | -82.78% | 0.05% |
| TREXQUANT INVESTMENT LP | 08/13/2024 | 43,748 | $395,044 | -54.68% | 0.04% |
| CITADEL ADVISORS LLC | 08/14/2024 | 38,276 | $345,632 | -18.51% | 0.04% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/09/2024 | 33,539 | $302,857 | 0.00% | 0.03% |
| RATHBONES GROUP PLC | 08/09/2024 | 31,300 | $282,639 | 0.00% | 0.03% |
| CUBIST SYSTEMATIC STRATEGIES, LLC | 09/16/2024 | 26,073 | $235,439 | -64.09% | 0.03% |
Centessa Pharmaceuticals plcinstitutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of CNTA shares?
During the previous two years, 88 institutional investors and hedge funds held shares of Centessa Pharmaceuticals plc. The most heavily invested institutionals were:
Medicxi Ventures Management (Jersey) Ltd: 19.96 M
GENERAL ATLANTIC, L.P.: 9.68 M
EcoR1 Capital, LLC: 5.71 M
First Light Asset Management, LLC: 4.78 M
PERCEPTIVE ADVISORS LLC: 3.93 M
Vida Ventures Advisors, LLC: 3.93 M
-
What percentage of Centessa Pharmaceuticals plc stock is owned by institutional investors?
86.60% of Centessa Pharmaceuticals plc stock is owned by institutional investors.
-
How much institutional buying is happening at CNTA ?
Institutional investors have bought a total of 99.41 M shares in the last 24 months. This purchase volume represents approximately $1.59 B in transactions.